检索
AI 对话
analysis
趋势分析
编组
开放平台
more
更多
排名必读论文期刊顶会热点AI 简史溯源树小脉星探人才迁徙塔尖人才国防情报追踪开源工具智慧手语
VIPCreated with Sketch.

MO4-4 Safety of immune checkpoint blockade in lung cancer and pre-existing autoimmune diseases: NEJ047 multi-center study

Rui Kitadai,Tetsuhiko Asao,Takehito Shukuya,Gaku Yamamoto,Atsuto Mouri,Ryosuke Imai,Yoko Tsukita,Kazutoshi Isobe,Satoshi Watanabe,Mitsuhiro Kamimura,Ryo Morita,Keita Kudo,Minehiko Inomata,Kazunari Tateishi,Kazutaka Kakinuma,Hiroshige Yoshioka,Yukiko Namba,Taku Nakagawa,Kunihiko Kobayashi,Kazuhisa Takahashi

Annals of Oncology（2022）

引用 0|浏览1
暂无评分
摘要
The safety and efficacy of immune checkpoint blockade (ICB) in patients with non-small cell lung cancer (NSCLC) and pre-existing autoimmune disease (AID) remain unclear since clinical trials have excluded these populations.
更多
查看译文
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要